Cargando…
Epigenetic Mechanisms Influencing Therapeutic Response in Breast Cancer
The majority of breast cancers are estrogen receptor (ER)+ and agents targeting the ER signaling pathway have markedly increased survival for women with breast cancer for decades. However, therapeutic resistance eventually emerges, especially in the metastatic setting. In the past decade disrupted e...
Autores principales: | Arruabarrena-Aristorena, Amaia, Toska, Eneda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239340/ https://www.ncbi.nlm.nih.gov/pubmed/35774123 http://dx.doi.org/10.3389/fonc.2022.924808 |
Ejemplares similares
-
Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism
por: Arruabarrena-Aristorena, Amaia, et al.
Publicado: (2018) -
Chromatin regulation at the intersection of estrogen receptor and PI3K pathways in breast cancer
por: Castel, Pau, et al.
Publicado: (2019) -
The Oncogenic PI3K-Induced Transcriptomic Landscape Reveals Key Functions in Splicing and Gene Expression Regulation
por: Ladewig, Erik, et al.
Publicado: (2022) -
Aberrant Metabolism as Inductor of Epigenetic Changes in Breast Cancer: Therapeutic Opportunities
por: Coronel-Hernández, Jossimar, et al.
Publicado: (2021) -
HEY1 functions are regulated by its phosphorylation at Ser-68
por: López-Mateo, Irene, et al.
Publicado: (2016)